Device Orthopaedic

Equinoxe

Payments companies reported to CMS as associated with Equinoxe. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$13Massociated payments (2023-2025)
719clinicians with associated payments
3companies reporting

By year

2023 $4.7M
2024 $5.0M
2025 $3.4M

Payments reported as associated with Equinoxe, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $8.9M
Sports Medicine (Orthopaedic Surgery) $1.7M
Surgery of The Hand (Surgery) $1.3M
Hand Surgery $522K
Adult Reconstructive Orthopaedic Surgery $465K
Foot and Ankle Surgery $47K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Equinoxe

These are the largest totals companies reported as associated with Equinoxe. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Joseph Zuckerman New York, NY Orthopaedic Surgery $3,925,047.28
Thomas Wright Gainesville, FL Surgery of The Hand (Surgery) $1,320,474.15
Thomas Throckmorton Germantown, TN Orthopaedic Surgery $750,195.55
Stephen Brockmeier Charlottesville, VA Sports Medicine (Orthopaedic Surgery) $679,837.03
Rahul Deshmukh Jacksonville, FL Orthopaedic Surgery $481,014.12
Emilie Cheung Stanford, CA Hand Surgery $476,709.31
Howard Routman Atlantis, FL Orthopaedic Surgery $470,279.64
Lawrence Gulotta New York, NY Orthopaedic Surgery $396,437.97
Ryan Simovitch West Palm Beach, FL Sports Medicine (Orthopaedic Surgery) $380,189.24
Sean Grey Fort Collins, CO Adult Reconstructive Orthopaedic Surgery $330,237.04

Prescribed Equinoxe?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.